Deliver Your News to the World

Human alpha 1 antitrypsin market update, A1AT research


Lee Biosolutions( announces the availability of Alpha-1 antitrypsin Antigen to clinical researchers worldwide. Alpha-1 antitrypsin is a protein produced in the liver that blocks the destructive effects of certain enzymes.

An Alpha-1 antitrypsin Antigen concentration test is used as a tool to help diagnose the cause of early onset emphysema, especially when a person does not present obvious risk factors, like smoking or exposure to lung irritants such as dust and fumes. Alpha-1 antitrypsin tests are also implemented in diagnosing the cause of persistent jaundice and liver dysfunction indicators, primarily in young children.

According to Lee Biosolutions President Burton Lee, the company continues to introduce new products on a regular basis in order to stay ahead of the demands of the clinical research community.

“Production of proteins like alpha-1 antitrypsin is the result of a need by researchers for pure and consistent products.” Lee said.

If a patient’s alpha-1 antitrypsin concentration is below normal, Alpha-1 antitrypsin Antigen phenotype testing may be ordered. That testing is sometimes followed by DNA testing to establish which Pi gene alleles are present.

Lee Biosolutions also offers affinity purified polyclonal antibodies of goat anti-human alpha-1 antitrypsin and polyclonal chicken anti-human alpha-1 anti-trypsin .

Lee Biosolutions is a leader in the biomarker industry, providing quality products to clinical labs and researchers around the world, developing tomorrow’s cures. LeeBio has provided human proteins used in a number of high profile biomarker studies. For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company’s website,


 alpha 1 antitrypsin
 liver disease
 lung disease

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.